SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-14-048103
Filing Date
2014-08-08
Accepted
2014-08-08 16:30:15
Documents
1
Group Members
ORBIMED CAPITAL GP V LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SC 13D v386255_13d.htm SC 13D 107453
  Complete submission text file 0001144204-14-048103.txt   108986
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-658-4749
Loxo Oncology, Inc. (Subject) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88267 | Film No.: 141027825
SIC: 2834 Pharmaceutical Preparations